儿童哮喘:发病机制与表型
本文综述儿童哮喘发病机制中2型炎症反应的关键作用,涉及感染、特应性、遗传易感性与环境暴露的交互影响,以及免疫系统、肺功能与微生物组的平行发育。文章讨论基于临床参数的表型和基于病理生理机制的内型分类,指出无偏数据驱动聚类有助于更好定义表型,并提及炎症表型知识已成功应用于严重治疗抵抗性哮喘儿童的生物制剂治疗。
要点
- 2型炎症反应在儿童哮喘发病机制中起关键作用,受感染、特应性、遗传与环境暴露交互影响。
- 肠道与气道微生物组失调可能是哮喘发展的重要因素,婴儿体重增长增加与早产也是危险因素。
- 儿童哮喘表型与内型分类有助于改善诊断、预测哮喘发展及个体化治疗。
核心结论
- 儿童哮喘发病机制中2型炎症反应对早期生活暴露或事件起关键作用。
- 感染、特应性、遗传易感性与环境暴露之间的交互影响喘息性疾病发展及进展为哮喘的风险。
- 基于临床参数的表型或基于特定病理生理机制的内型可识别患者亚组,最终可能帮助改善哮喘诊断、预测哮喘发展及个体化治疗。
研究设计与样本
- 综述类文章,检索范围未在原文中报告。
主要发现
- 免疫系统、肺功能及肠道与气道微生物组平行发育,微生物组失调可能是哮喘发展的关键因素。
- 婴儿体重增长增加与早产是哮喘发展及肺功能降低的其他危险因素。
- 这些因素的复杂相互作用解释了儿童哮喘的异质性。
- 儿童哮喘炎症表型的现有知识已成功应用于严重治疗抵抗性哮喘儿童的生物制剂治疗。
关键数值与推荐
- 基于临床参数可识别表型,基于特定病理生理机制可识别内型。
- 可能需要无偏数据驱动聚类,使用多维或系统生物学方法来更好地定义表型。
临床怎么用
- 儿科哮喘表型和内型可能最终帮助基于临床、时间、发育或炎症特征改善哮喘诊断、预测哮喘发展及个体化治疗。
- 儿童哮喘炎症表型知识已应用于严重治疗抵抗性哮喘儿童的生物制剂治疗。
- 预计更多个体化治疗选择可能变得可用。
局限性
- 原文未报告综述的检索范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the pathogenesis of asthma in children there is a pivotal role for a type 2 inflammatory response to early life exposures or events. Interactions between infections, atopy, genetic susceptibility and environmental exposures (such as farmyard environment, air pollution and tobacco smoke exposure) influence the development of wheezing illness and the risk of progression to asthma. The immune system, lung function and the microbiome in gut and airways develop in parallel, and dysbiosis of the microbiome may be a critical factor in asthma development. Increased infant weight gain and preterm birth are other risk factors for development of asthma and reduced lung function. The complex interplay between these factors explains the heterogeneity of asthma in children. Subgroups of patients can be identified as phenotypes, based on clinical parameters, or endotypes, based on a specific pathophysiological mechanism. Paediatric asthma phenotypes and endotypes may ultimately help to improve diagnosis of asthma, prediction of asthma development and treatment of individual children, based on clinical, temporal, developmental or inflammatory characteristics. Unbiased, data-driven clustering, using a multidimensional or systems biology approach may be needed to better define phenotypes. The present knowledge on inflammatory phenotypes of childhood asthma has now been successfully applied in the treatment with biologicals of children with severe therapy-resistant asthma, and it is to be expected that more personalised treatment options may become available.
引用
- Pijnenburg MW, Frey U, De Jongste JC, et al. Childhood asthma: pathogenesis and phenotypes. Eur Respir J. 2022. PMID: 34711541. doi:10.1183/13993003.00731-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。